Income Statement Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 13:59:17 2026-04-14 EDT			5-day change	1st Jan Change
3.265 ^USD	+1.08%		-3.25%	-9.42%

04-01	Lilly gains after FDA approves weight-loss pill, sizing down investor doubts	RE
03-19	Truist Initiates Altimmune at Buy With $12 Price Target	MT

1b9a9b.pWgLYNr543F5TfBeMeR5EG8rGshMwLJQD4nVptYJCzI.1AFsDrOhhTc1PKFqZIYgfEJOWbEjmt0aWNvh6b9QZXGQP2Uil8rTORJ9pQ

Published financial data: ALTIMMUNE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.41M	-68K	426K	20K	41K
Total Revenues	4.41M	-68K	426K	20K	41K
Cost of Goods Sold, Total	73.84M	70.45M	65.8M	82.23M	66.43M
Gross Profit	-69.43M	-70.52M	-65.37M	-82.21M	-66.39M
Selling General & Admin Expenses, Total	15.41M	17.13M	18.14M	20.97M	28.1M
Other Operating Expenses, Total	15.41M	17.13M	18.14M	20.97M	28.1M
Operating Income	-84.84M	-87.65M	-83.51M	-103M	-94.49M
Interest Expense, Total	-5.66K	-8K	-35K	-9K	-1.64M
Interest And Investment Income	203K	2.87M	7.35M	8.07M	7.54M
Net Interest Expenses	197K	2.86M	7.32M	8.06M	5.9M
Other Non Operating Income (Expenses)	-374K	-32K	166K	48K	-190K
EBT, Excl. Unusual Items	-85.02M	-84.82M	-76.03M	-95.06M	-88.77M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-11.37M	-	-12.42M	-	-
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-700K	-86K	-	-	-
EBT, Incl. Unusual Items	-97.09M	-84.91M	-88.45M	-95.06M	-88.77M
Income Tax Expense	-	-197K	-	-	-681K
Earnings From Continuing Operations	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Net Income to Company	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Net Income - (IS)	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Net Income to Common Excl. Extra Items	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Per Share Items
Net EPS - Basic	-2.35	-1.81	-1.66	-1.34	-1
Basic EPS - Continuing Operations	-2.35	-1.81	-1.66	-1.34	-1
Basic Weighted Average Shares Outstanding	41.28M	46.93M	53.25M	71M	88.1M
Net EPS - Diluted	-2.35	-1.81	-1.66	-1.34	-1
Diluted EPS - Continuing Operations	-2.35	-1.81	-1.66	-1.34	-1
Diluted Weighted Average Shares Outstanding	41.28M	46.93M	53.25M	71M	88.1M
Normalized Basic EPS	-1.29	-1.13	-0.89	-0.84	-0.63
Normalized Diluted EPS	-1.29	-1.13	-0.89	-0.84	-0.63
Supplemental Items
EBITDA	-84.29M	-87.61M	-83.03M	-103M	-94.38M
EBITA	-84.82M	-87.65M	-83.51M	-103M	-94.49M
EBIT	-84.84M	-87.65M	-83.51M	-103M	-94.49M
EBITDAR	-83.79M	-87.11M	-82.53M	-102M	-93.78M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	0.23	-	-	0.77
Current Domestic Taxes	-	-197K	-	-	-
Total Current Taxes	-	-197K	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-53.14M	-53.02M	-47.52M	-59.41M	-55.48M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	15.41M	17.13M	18.14M	20.97M	28.1M
Research And Development Expense From Footnotes	74.54M	70.54M	65.8M	82.23M	66.43M
Net Rental Expense, Total	500K	500K	500K	500K	600K
Imputed Operating Lease Interest Expense	13.46K	24.07K	156K	30.61K	420K
Imputed Operating Lease Depreciation	487K	476K	344K	469K	180K
Stock-Based Comp., COGS (Total)	1.66M	2.84M	4.76M	6.35M	6.17M
Stock-Based Comp., G&A Exp. (Total)	3.86M	5.27M	5.88M	8.04M	9.91M
Total Stock-Based Compensation	5.52M	8.1M	10.64M	14.39M	16.08M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	190M	111M	135M	36.93M	43.76M
Short Term Investments	-	73.78M	62.7M	94.96M	230M
Total Cash And Short Term Investments	190M	185M	198M	132M	273M
Accounts Receivable, Total	429K	173K	1.11M	544K	1.22M
Other Receivables	5.41M	2.37M	3.74M	2.57M	518K
Total Receivables	5.84M	2.54M	4.85M	3.12M	1.74M
Prepaid Expenses	7.95M	5.36M	6.82M	2.1M	2.76M
Restricted Cash	34.17K	34K	41K	42K	42K
Other Current Assets, Total	-	-	100K	100K	200K
Total Current Assets	204M	193M	210M	137M	278M
Gross Property Plant And Equipment	4.29M	3.18M	2.99M	4.26M	4.06M
Accumulated Depreciation	-2.05M	-1.5M	-1.98M	-2.21M	-2.32M
Net Property Plant And Equipment	2.25M	1.68M	1.01M	2.05M	1.74M
Goodwill	-	-	-	-	-
Other Intangibles, Total	12.42M	12.42M	-	-	-
Other Long-Term Assets, Total	73.8K	19K	-	-	-
Total Assets	219M	207M	211M	139M	280M
Liabilities
Accounts Payable, Total	2.03M	4.8M	2.07M	211K	2.72M
Accrued Expenses, Total	9.74M	10.63M	9.58M	9.98M	12.02M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	411K	452K	496K	279K	256K
Current Income Taxes Payable	-	1.17M	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	6.09M	-	-	-	-
Total Current Liabilities	18.28M	17.05M	12.14M	10.47M	15M
Long-Term Debt	-	-	-	-	34.29M
Long-Term Leases	1.12M	672K	175K	1.4M	1.14M
Unearned Revenue Non Current	250K	250K	160K	160K	160K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	80.54K	3.66M	4.06M	3.77M	4.45M
Total Liabilities	19.73M	21.64M	16.54M	15.8M	55.04M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	4.09K	5K	7K	7K	11K
Additional Paid In Capital	497M	568M	665M	690M	879M
Retained Earnings	-293M	-378M	-466M	-561M	-649M
Comprehensive Income and Other	-5.04M	-5.23M	-5M	-4.97M	-4.93M
Total Common Equity	199M	185M	194M	124M	225M
Total Equity	199M	185M	194M	124M	225M
Total Liabilities And Equity	219M	207M	211M	139M	280M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	42.92M	49.28M	70.9M	77.01M	130M
ECS Total Common Shares Outstanding	40.69M	49.2M	70.68M	72.35M	111M
Book Value / Share	4.89	3.77	2.75	1.71	2.03
Tangible Book Value	187M	173M	194M	124M	225M
Tangible Book Value Per Share	4.59	3.51	2.75	1.71	2.03
Total Debt	1.54M	1.12M	671K	1.68M	35.69M
Net Debt	-189M	-184M	-197M	-130M	-238M
Debt Equivalent Oper. Leases	4M	4M	4M	4M	4.8M
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	1.55M	652K	699K	699K	710K
Full Time Employees	47	52	59	59	57

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-97.09M	-84.71M	-88.45M	-95.06M	-88.09M
Depreciation & Amortization - CF	531K	-205K	477K	238K	112K
Amortization of Goodwill and Intangible Assets - (CF)	19.92K	-	-	-	-
Depreciation & Amortization, Total	551K	-205K	477K	238K	112K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-2.47M	-3.85M	-2.22M
Asset Writedown & Restructuring Costs	11.95M	-	12.42M	-	-
Stock-Based Compensation (CF)	5.52M	8.1M	10.64M	14.39M	16.08M
Other Operating Activities, Total	1.08M	120K	-154K	-48K	-158K
Change In Accounts Receivable	4.18M	256K	-938K	567K	-675K
Change In Accounts Payable	1.42M	2.77M	-2.73M	-1.86M	2.51M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	2.35M	3.04M	-1.37M	1.17M	2.74M
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-8.21M	8.04M	-3.23M	4.6M	2.18M
Cash from Operations	-78.24M	-62.59M	-75.81M	-79.85M	-67.54M
Capital Expenditure	-12.12M	-126K	-47K	-	-11K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-195K	-	-	-	-
Investment in Marketable and Equity Securities, Total	99.83M	-73.27M	13.78M	-28.39M	-132M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	87.52M	-73.4M	13.73M	-28.39M	-132M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	35M
Total Debt Issued	-	-	-	-	35M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	65.22M	56.78M	86.93M	10.89M	174M
Repurchase of Common Stock	-	-	-539K	-850K	-709K
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-119K	-	-285K	-	-1.51M
Cash from Financing	65.1M	56.78M	86.1M	10.04M	207M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	74.38M	-79.2M	24.03M	-98.19M	6.83M
Supplemental Items
Cash Interest Paid	-	-	-	-	975K
Cash Income Tax Paid (Refund)	-	-	-	-	1.42M
Levered Free Cash Flow	-52.56M	-42.39M	-49.98M	-44.87M	-38.72M
Unlevered Free Cash Flow	-52.56M	-42.38M	-49.96M	-44.86M	-37.7M
Change In Net Working Capital	-6.71M	-4.63M	8.83M	-4.99M	-5.18M
Net Debt Issued / Repaid	-	-	-	-	35M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-22.86	-25.73	-25	-36.85	-28.17
Return on Total Capital	-24.76	-28.31	-27.38	-40.31	-30.62
Return On Equity %	-45.69	-44.07	-46.63	-59.86	-50.57
Return on Common Equity	-45.69	-44.07	-46.63	-59.86	-50.57
Margin Analysis
Gross Profit Margin %	-1.57K	104K	-15.35K	-411K	-162K
SG&A Margin	349.48	-25.2K	4.26K	105K	68.53K
EBITDA Margin %	-1.91K	129K	-19.49K	-515K	-230K
EBITA Margin %	-1.92K	129K	-19.6K	-516K	-230K
EBIT Margin %	-1.92K	129K	-19.6K	-516K	-230K
Income From Continuing Operations Margin %	-2.2K	125K	-20.76K	-475K	-215K
Net Income Margin %	-2.2K	125K	-20.76K	-475K	-215K
Net Avail. For Common Margin %	-2.2K	125K	-20.76K	-475K	-215K
Normalized Net Income Margin	-1.2K	77.96K	-11.15K	-297K	-135K
Levered Free Cash Flow Margin	-1.19K	62.34K	-11.73K	-224K	-94.44K
Unlevered Free Cash Flow Margin	-1.19K	62.33K	-11.73K	-224K	-91.95K
Asset Turnover
Asset Turnover	0.02	-0	0	0	0
Fixed Assets Turnover	2.1	-0.03	0.32	0.01	0.02
Receivables Turnover (Average Receivables)	1.75	-0.23	0.66	0.02	0.05
Short Term Liquidity
Current Ratio	11.17	11.31	17.26	13.11	18.55
Quick Ratio	10.73	10.99	16.69	12.9	18.35
Operating Cash Flow to Current Liabilities	-4.28	-3.67	-6.24	-7.63	-4.5
Days Sales Outstanding (Average Receivables)	208.51	-1.62K	550.07	15.14K	7.85K
Average Days Payable Outstanding	6.54	17.71	19.07	5.08	8.04
Long Term Solvency
Total Debt/Equity	0.77	0.61	0.35	1.36	15.87
Total Debt / Total Capital	0.76	0.6	0.34	1.34	13.7
LT Debt/Equity	0.56	0.36	0.09	1.14	15.76
Long-Term Debt / Total Capital	0.56	0.36	0.09	1.12	13.6
Total Liabilities / Total Assets	9.01	10.46	7.85	11.34	19.66
EBIT / Interest Expense	-15K	-10.96K	-2.39K	-11.46K	-57.76
EBITDA / Interest Expense	-14.81K	-10.89K	-2.36K	-11.38K	-57.32
(EBITDA - Capex) / Interest Expense	-16.96K	-10.9K	-2.36K	-11.38K	-57.33
Total Debt / EBITDA	-0.02	-0.01	-0.01	-0.02	-0.38
Net Debt / EBITDA	2.25	2.11	2.39	1.27	2.54
Total Debt / (EBITDA - Capex)	-0.02	-0.01	-0.01	-0.02	-0.38
Net Debt / (EBITDA - Capex)	1.97	2.11	2.39	1.27	2.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-46.12	-101.54	-726.47	-95.31	105
Gross Profit, 1 Yr. Growth %	174.17	1.57	-7.3	25.75	-19.24
EBITDA, 1 Yr. Growth %	121.21	3.94	-4.74	23.97	-8.31
EBITA, 1 Yr. Growth %	120.4	3.31	-4.73	23.54	-8.42
EBIT, 1 Yr. Growth %	120.18	3.31	-4.73	23.54	-8.42
Earnings From Cont. Operations, 1 Yr. Growth %	97.96	-12.75	4.41	7.48	-7.33
Net Income, 1 Yr. Growth %	97.96	-12.75	4.41	7.48	-7.33
Normalized Net Income, 1 Yr. Growth %	122.59	-0.23	-10.37	25.03	-6.61
Diluted EPS Before Extra, 1 Yr. Growth %	22.94	-23.04	-8.23	-19.4	-25.32
Accounts Receivable, 1 Yr. Growth %	-90.7	-59.67	542.2	-51.04	124.08
Net Property, Plant and Equip., 1 Yr. Growth %	14.55	-25.33	-39.53	102.37	-15.35
Total Assets, 1 Yr. Growth %	-10.71	-5.45	1.79	-33.87	100.95
Tangible Book Value, 1 Yr. Growth %	-12.36	-7.41	12.28	-36.37	82.09
Common Equity, 1 Yr. Growth %	-11.84	-6.95	4.75	-36.37	82.09
Cash From Operations, 1 Yr. Growth %	128.06	-20.01	21.13	5.33	-15.42
Capital Expenditures, 1 Yr. Growth %	5.84K	-98.96	-62.7	-	-
Levered Free Cash Flow, 1 Yr. Growth %	105.28	-19.35	19.88	-10.23	-13.7
Unlevered Free Cash Flow, 1 Yr. Growth %	105.31	-19.36	19.84	-10.2	-15.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-12.81	-90.89	-68.92	-45.77	-68.98
Gross Profit, 2 Yr. CAGR %	148.27	66.87	-2.97	7.97	0.78
EBITDA, 2 Yr. CAGR %	108.57	51.63	-0.75	8.67	6.61
EBITA, 2 Yr. CAGR %	107.94	50.91	-0.79	8.49	6.37
EBIT, 2 Yr. CAGR %	107.19	50.82	-0.79	8.49	6.37
Earnings From Cont. Operations, 2 Yr. CAGR %	117.52	31.43	-4.55	5.93	-0.2
Net Income, 2 Yr. CAGR %	117.52	31.43	-4.55	5.93	-0.2
Normalized Net Income, 2 Yr. CAGR %	112.22	49.02	-5.44	5.86	8.06
Diluted EPS Before Extra, 2 Yr. CAGR %	21.32	-2.73	-15.96	-14	-22.41
Accounts Receivable, 2 Yr. CAGR %	-35.2	-80.63	60.93	77.33	4.75
Net Property, Plant and Equip., 2 Yr. CAGR %	11.62	-7.52	-32.81	10.62	30.88
Total Assets, 2 Yr. CAGR %	101.21	-8.12	-1.9	-17.95	15.28
Tangible Book Value, 2 Yr. CAGR %	138.63	-9.92	1.96	-15.48	7.64
Common Equity, 2 Yr. CAGR %	109.16	-9.43	-1.27	-18.36	7.64
Cash From Operations, 2 Yr. CAGR %	185.45	35.07	-1.56	12.95	-5.62
Capital Expenditures, 2 Yr. CAGR %	9.84K	-21.4	-93.77	-	-51.62
Levered Free Cash Flow, 2 Yr. CAGR %	155.92	28.66	-2.49	3.74	-11.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	155.94	28.67	-2.51	3.74	-13.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-24.7	-77.28	-62.66	-83.45	-15.52
Gross Profit, 3 Yr. CAGR %	104.42	84.31	37.18	5.79	-1.99
EBITDA, 3 Yr. CAGR %	68.59	65.36	29.65	6.89	2.69
EBITA, 3 Yr. CAGR %	68.25	64.71	29.46	6.74	2.53
EBIT, 3 Yr. CAGR %	68	64.3	29.41	6.74	2.53
Earnings From Cont. Operations, 3 Yr. CAGR %	35.33	60.42	21.72	-0.7	1.31
Net Income, 3 Yr. CAGR %	35.33	60.42	21.72	-0.7	1.31
Normalized Net Income, 3 Yr. CAGR %	60.98	65.01	25.79	3.79	1.53
Diluted EPS Before Extra, 3 Yr. CAGR %	-46.27	4.24	-4.6	-17.12	-17.95
Accounts Receivable, 3 Yr. CAGR %	-50.15	-44.67	-37.77	8.24	91.71
Net Property, Plant and Equip., 3 Yr. CAGR %	18.7	-2.38	-19.73	-2.97	1.18
Total Assets, 3 Yr. CAGR %	58.71	56.43	-4.93	-13.98	10.6
Tangible Book Value, 3 Yr. CAGR %	75.64	74.05	-3.06	-12.87	9.16
Common Equity, 3 Yr. CAGR %	60.34	59.67	-4.93	-14.72	6.67
Cash From Operations, 3 Yr. CAGR %	102.74	86.8	30.25	0.68	2.57
Capital Expenditures, 3 Yr. CAGR %	131.6	368.28	-38.69	-	-55.64
Levered Free Cash Flow, 3 Yr. CAGR %	233.28	74.15	24.97	-5.14	-2.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	233.67	74.16	24.96	-5.14	-3.3
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.39	-63.67	-47.15	-67.83	-65.33
Gross Profit, 5 Yr. CAGR %	77.1	55.86	51.73	48.81	21.26
EBITDA, 5 Yr. CAGR %	52.31	40.53	36.39	39.65	19.89
EBITA, 5 Yr. CAGR %	52.31	40.39	36.21	39.37	19.68
EBIT, 5 Yr. CAGR %	52.11	40.3	36.08	39.17	19.65
Earnings From Cont. Operations, 5 Yr. CAGR %	54.34	12.78	17.69	35.88	12.43
Net Income, 5 Yr. CAGR %	54.34	12.78	17.69	35.88	12.43
Normalized Net Income, 5 Yr. CAGR %	52.18	39.35	30.12	38.17	18.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-45.68	-56.7	-35.74	-3.48	-12.17
Accounts Receivable, 5 Yr. CAGR %	2.28	-46.11	-20.33	-11.83	-23.36
Net Property, Plant and Equip., 5 Yr. CAGR %	66.06	22.69	-5.46	2.63	-2.39
Total Assets, 5 Yr. CAGR %	41.63	26.84	30.93	20.84	2.69
Tangible Book Value, 5 Yr. CAGR %	162.02	203.3	41.3	30.38	1.09
Common Equity, 5 Yr. CAGR %	43.96	36.3	32.07	22.1	-0.09
Cash From Operations, 5 Yr. CAGR %	65.23	25.36	51.85	52.75	14.51
Capital Expenditures, 5 Yr. CAGR %	149.65	2.3	-45.48	-	-44.23
Levered Free Cash Flow, 5 Yr. CAGR %	92.78	13.03	103.85	41.09	8.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	93.26	13.03	103.98	41.09	8.05